Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1729INDUSTRY 564NIH 100OTHER_GOV 53NETWORK 13FED 7UNKNOWN 4INDIV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 7Barrett Esophagus 5Carcinoma, Hepatocellular 3Breast Neoplasms 3Multiple Myeloma 2Lymphoma, Follicular 2Lipoma 2Leiomyoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma in Situ 2Warts 1Vaginosis, Bacterial 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Syphilis 1Sexually Transmitted Diseases 1Retroperitoneal liposarcoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pilonidal Sinus 1Papillomavirus Infections 1Overweight 1Ovarian Neoplasms 1Osteosarcoma 1Obesity 1Neutropenia 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Myasthenia Gravis 1Melanoma 1

Interventions

Everolimus 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDIV × Interventional × Carcinoma, Hepatocellular × Clear all
NCT05178303 2025-05-16

SB-1121

Trieu, Nguyen Thi, M.D.

Phase 4 Completed
134 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT00775073 2012-04-30

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Treiber, Gerhard

Phase 2 Completed
33 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00440934 2008-05-06

THBC002

Pasche, Boris, M.D.

Phase 2 Terminated
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡